بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
-
1801
-
1802
-
1803
-
1804
-
1805
ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side.
منشور في 2025الموضوعات: -
1806
-
1807
-
1808
-
1809
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
منشور في 2025الموضوعات: -
1810
-
1811
-
1812
Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells.
منشور في 2024الموضوعات: -
1813
-
1814
-
1815
Causal relationships between allergic diseases and significant declines in lung function: a multivariable Mendelian randomization study
منشور في 2025"…However, in multivariable MR analysis, the independent effects of atopic dermatitis and allergic conjunctivitis on lung function were no longer significant. Only allergic asthma continued to show a significant causal relationship with decreased lung function (OR [95%CI]: 1.019 [1.008–1.030], <i>p</i> < .001).…"
-
1816
Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells.
منشور في 2024الموضوعات: -
1817
Amino acids interactions and binding energy describe that ABT-199 binds to ALK<sup>Mutant</sup>.
منشور في 2025الموضوعات: -
1818
BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>.
منشور في 2025الموضوعات: -
1819
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
منشور في 2025الموضوعات: -
1820
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
منشور في 2025الموضوعات: